| TT |
Report |
Adjusted EPS (Q2 2026) |
BEAT |
pred ~$4.31 vs. cons $4.27 |
MEDIUM |
| TT |
Report |
Total Revenue (Q2 2026) |
BEAT |
pred ~$6.30B vs. cons $6.20B |
MEDIUM |
| TT |
Report |
Enterprise Adjusted Operating Margin / Incremental Leverage |
IN-LINE |
pred ~24.0% incremental leverage vs. cons ~25% (mid-20s guided) |
MEDIUM |
| TT |
Guide |
FY2026 Adjusted EPS guidance |
BETTER |
guide ~$14.90-$15.10 vs. cons $14.85 (FY2026) |
MEDIUM |
| TT |
Guide |
FY2026 Organic Revenue Growth guidance |
BETTER |
guide ~7-8% vs. cons ~7% (FY2026) |
MEDIUM |
| TT |
Guide |
Tariff/Inflation net cost headwind (enterprise points) |
UNCHANGED |
guide ~2.0-2.2 pts vs. cons ~2.0 pts (FY2026) |
LOW |
| TT |
Guide |
Residential segment outlook (revenue growth) |
UNCHANGED |
guide ~flat to +low-single-digit vs. cons flat (FY2026) |
LOW |
| TT |
Guide |
Q3 2026 organic revenue growth guide |
BETTER |
guide ~8-9% vs. cons ~7.5% (Q3 2026) |
LOW |
| TT |
Return |
Day-1 residual (stock − beta × S&P 500) |
+2.5% |
— |
MEDIUM |
| TT |
Return |
5-day cumulative residual |
+3.2% (FOLLOW-THROUGH) |
TT's backlog ($10.7B, +30% YoY) and three straight quarters of >100% Applied bookings growth give visibility into H2/FY revenue acceleration that a beat-and-raise merely confirms rather than surprises, but the magnitude of the FY EPS raise (following the established quarterly cadence of raising ~$0.10-0.20) combined with corroborating peer prints (CARR, JCI beat/raise) should support sell-side estimate revisions upward over the following days rather than a snap-back fade. The main fade risk (elevated tariff/inflation cost creep already flagged) is a known item, limiting negative surprise, so net drift should continue in the direction of the initial reaction, tempered versus a full follow-through by residential softness (Lennox read-through) and tough Transport comps capping enthusiasm. |
MEDIUM |